undamentalytics Newsletter
Sign in

Tela Bio, Inc. balance sheet

At the end of fiscal 2025, Tela Bio, Inc. had total assets of $81.4m, total liabilities of $75.1m and shareholders' equity of $6.3m. It held $50.8m in cash against $55.7m of debt: net debt of $4.8m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents11174574444247535130
Receivables—1334710101010
Inventory—45481213131111
Total current assets—236483596272787654
Total assets—276886636878878160
Accounts payable—331222223
Total current liabilities—1077111217161818
Long-term debt——3031314041415656
Total debt003031314041415656
Total liabilities—413737425459587576
Shareholders' equity−108−1383149201419286−16
Non-controlling interests and other (assets − liabilities − equity)—124————————
Net debt (negative = net cash)−11−17−15−44−12−2−6−12526
Shares outstanding———14m15m19m24m—45m45m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: PDEX vs TELASGHT vs TELARCEL vs TELAELMD vs TELA

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Tela Bio, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Tela Bio, Inc.